secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rallybio Corp (RLYB)
CIK:        0001739410
Form:       8-K
Filed at:   2026-09-09T20:30:24+00:00
Accession:  0001193125-26-386511
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rallybio CFO Lieber goes part-time Sept 15, $420k salary, no bonus, until Avenzo merger closes
--------------------------------------------------------------------------------

- CFO Jonathan Lieber transitions to part-time effective Sept 15, 2026; retains CFO and Principal Financial Officer roles.
- Base salary set at $420,000 annualized; no annual bonus for 2026 or any later year while employed.
- Employment terminates upon closing of pending merger with Avenzo Therapeutics (agreement dated May 31, 2026).
- Severance per existing employment agreement; equity awards remain eligible to vest per merger terms.
- Lieber may engage in other business activities while part-time, subject to no conflicts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739410/000119312526386511/0001193125-26-386511-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739410/000119312526386511/d96849d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-386511

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer